- Home
- FMBH vs PRTA Comparison
FMBH vs PRTA Comparison
Compare FMBH & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- PRTA
- Stock Information
- Founded
- FMBH 1865
- PRTA 2012
- Country
- FMBH United States
- PRTA Ireland
- Employees
- FMBH N/A
- PRTA N/A
- Industry
- FMBH Major Banks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- PRTA Health Care
- Exchange
- FMBH Nasdaq
- PRTA Nasdaq
- Market Cap
- FMBH 853.8M
- PRTA 809.8M
- IPO Year
- FMBH N/A
- PRTA N/A
- Fundamental
- Price
- FMBH $39.43
- PRTA $6.58
- Analyst Decision
- FMBH Hold
- PRTA Buy
- Analyst Count
- FMBH 5
- PRTA 9
- Target Price
- FMBH $44.00
- PRTA $27.67
- AVG Volume (30 Days)
- FMBH 81.9K
- PRTA 1.7M
- Earning Date
- FMBH 07-31-2025
- PRTA 08-07-2025
- Dividend Yield
- FMBH 2.44%
- PRTA N/A
- EPS Growth
- FMBH 8.80
- PRTA N/A
- EPS
- FMBH 3.37
- PRTA N/A
- Revenue
- FMBH $321,695,000.00
- PRTA $137,935,000.00
- Revenue This Year
- FMBH N/A
- PRTA N/A
- Revenue Next Year
- FMBH $4.02
- PRTA $119.20
- P/E Ratio
- FMBH $11.69
- PRTA N/A
- Revenue Growth
- FMBH 11.71
- PRTA 54.55
- 52 Week Low
- FMBH $27.58
- PRTA $4.32
- 52 Week High
- FMBH $43.86
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- FMBH 67.05
- PRTA 59.96
- Support Level
- FMBH $38.83
- PRTA $5.96
- Resistance Level
- FMBH $39.92
- PRTA $6.59
- Average True Range (ATR)
- FMBH 1.08
- PRTA 0.38
- MACD
- FMBH 0.28
- PRTA 0.15
- Stochastic Oscillator
- FMBH 98.00
- PRTA 83.93
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).